Blueprint Medicines Corp
NASDAQ:BPMC
Wall Street
Price Targets
BPMC Price Targets Summary
Blueprint Medicines Corp
According to Wall Street analysts, the average 1-year price target for
BPMC
is 120.49 USD
with a low forecast of 75.75 USD and a high forecast of 176.4 USD.
BPMC Last Price Targets
Blueprint Medicines Corp
The latest public price target was made on May 6, 2024 by
Andrew Berens
from
Leerink Partners
,
who expects
BPMC
stock to
drop by 11%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Andrew Berens
Leerink Partners
|
97
USD
Downside 11% |
3 days ago
May 6, 2024
|
Leerink Partners Upgrades Blueprint Medicines (BPMC) to Market Perform
StreetInsider
|
Christopher Raymond
Raymond James
|
104
USD
Downside 4% |
6 days ago
May 3, 2024
|
Blueprint Medicines (BPMC) PT Raised to $104 at Piper Sandler
StreetInsider
|
|
Andrew Fein
H.C. Wainwright
|
135
USD
Upside 24% |
6 days ago
May 3, 2024
|
Blueprint Medicines price target raised to $135 from $125 at H.C. Wainwright
TheFly
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BPMC's stock price target?
Price Target
120.49
USD
According to Wall Street analysts, the average 1-year price target for
BPMC
is 120.49 USD
with a low forecast of 75.75 USD and a high forecast of 176.4 USD.
What is Blueprint Medicines Corp's Revenue forecast?
Projected CAGR
50%
For the last 8 years the
compound annual growth rate for
Blueprint Medicines Corp's revenue is
47%.
The projected
CAGR
for the next 3 years is
50%.
You don't have any saved screeners yet
